Xenetic Biosciences Inc. (NASDAQ: XBIO)
$4.28
+0.2000 ( +4.90% ) 12.2K
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
Market Data
Open
$4.28
Previous close
$4.08
Volume
12.2K
Market cap
$6.46M
Day range
$4.05 - $4.33
52 week range
$2.87 - $5.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
8-k | 8K-related | 16 | May 22, 2024 |
8-k | 8K-related | 17 | May 10, 2024 |
10-q | Quarterly Reports | 45 | May 09, 2024 |
10-k/a | Quarterly Reports | 3 | Apr 26, 2024 |
8-k | 8K-related | 16 | Mar 22, 2024 |
10-k | Annual reports | 75 | Mar 21, 2024 |
8-k | 8K-related | 15 | Feb 12, 2024 |
3 | Insider transactions | 1 | Dec 18, 2023 |